The aim of this study was to identify the specific molecular biological features predicting the therapeutic outcomes of three bDMARDs, infliximab (IFX), tocilizumab (TCZ), and abatacept (ABT) by studying blood gene expression signature of patients prior to biologic treatment in a unified test platfo...
To evaluate whether ULK1 phosphorylates mineralocorticoid receptor, we performed in vitro phosphatase assay and determined phosphorylation sites by mass spectrometry.
